$Gilead Sciences is scheduled to announce Q3 earnings results on Wednesday, October 28th. Let’s Learn more about influenza concept stocks and track pharmaceutical industry trends.
Below are the noteworthy pharmaceutical stocks, arranged in the order of the release of earnings report for this new earnings season. This list is limited to companies which are publicly traded in the U.S..
1.JNJ$Johnson&Johnson
Earnings Release Time: Oct.12 Market Cap: $376.85B
2.ABT$Abbott
Earnings Release Time: Oct.21 Market Cap: $192.24B
3.PFE$Pfizer
Earnings Release Time: Oct.27 Market Cap: $207.99B
4.GILD$Gilead Sciences
Earnings Release Time: Oct.28 Market Cap: $75.24B
5.MRNA$Moderna
Earnings Release Time: Oct.28 Market Cap: $27.89B
6.ACOR$Acorda
Earnings Release Time: Nov. 3 Market Cap: $41.88M
7.AZN$AstraZeneca
Earnings Release Time: Nov. 5 Market Cap: $137.72B
8.ARPO$Aerpio Pharms
Earnings Release Time: Nov. 5 Market Cap: $54.69M
9.VXRT$VAXART
Earnings Release Time: Nov.10 Market Cap: $595.51M
10.INO$Inovio Pharma
Earnings Release Time: Nov.10 Market Cap: $1.86B
11.CODX$Co-Diagnostics
Earnings Release Time: Nov.11 Market Cap: $399.62M
12.CBLI $Cleveland Biolbs
Earnings Release Time: Nov.12 Market Cap: $35.14M
13.IBIO$IBIO
Earnings Release Time: Nov.12 Market Cap: $346.15M
These data were collected and compiled at 4:30, Oct. 27, 2020 EST.
Discussion: With more and more pharmaceutical stocks are releasing their Q3 earnings reports, What are your general thoughts and concerns about the pharmaceutical industry? If you own pharmaceutical stocks, what are your trading strategies for the next weeks?#Earnings Trading Strategies
Sound off in the Webull community and discuss with other investors. Let your trading expertise inspire others!
Disclaimer: The content on this page belongs to Webull Limited. It does not reflect the views of Webull and any of its subsidiaries or affiliates. It is meant for informational purposes only, is not intended to serve as a recommendation to buy or sell any security in a self-directed Webull account or any other account, and is not an offer or sale of a security. It is also not a research report and not intended to serve as the basis for any investment decision. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns.
https://www.webull.com/community/post/218776753550565376
No reviews yet.